You are here

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Urinary Incontinence
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- 18 years or older patients suffering from OAB symptoms (urinary frequency of at least
8 micturitions per 24h, urinary urgency and at least 3 urge urinary incontinence
episodes within 3 days), confirmed by a micturition bladder diary.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Other than urge incontinence

- History of prostate/uterine or other female organ cancer

NCT00143377
Pfizer
Completed
Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]izer.com

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now